Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,312 | 16,743 | 29,676 | 20,896 | 11,408 |
| Marketable Securities | 54 | 7,548 | 18,072 | 29,674 | 18,675 |
| Receivables | 3,287 | 3,880 | 4,046 | 3,919 | 3,905 |
| Other current assets | 0 | 0 | 0 | 0 | 1,000 |
| TOTAL | $9,874 | $28,592 | $52,258 | $54,867 | $35,326 |
| Non-Current Assets | |||||
| PPE Net | 172 | 264 | 621 | 848 | 915 |
| Other Non-Current Assets | 22 | 68 | 136 | 5 | 191 |
| TOTAL | $193 | $331 | $757 | $853 | $1,106 |
| Total Assets | $10,067 | $28,923 | $53,015 | $55,720 | $36,432 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,555 | 7,709 | 2,982 | 751 | N/A |
| Accounts payable and accrued liabilities | 1,969 | 3,496 | 4,551 | 5,947 | 5,715 |
| Accrued Expenses | 745 | 2,584 | 1,676 | 1,828 | 1,039 |
| TOTAL | $11,269 | $13,810 | $9,328 | $8,616 | $6,815 |
| Non-Current Liabilities | |||||
| Long Term Debt | 724 | 9,192 | 16,769 | N/A | N/A |
| Deferred Revenues | N/A | 21 | 120 | 90 | 61 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 17 |
| TOTAL | $724 | $9,192 | $16,790 | $140 | $247 |
| Total Liabilities | $11,993 | $23,001 | $26,118 | $8,756 | $7,063 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 870 | 797 | 780 | 772 | 582 |
| Common Shares | 81 | 885 | 857 | 848 | 511 |
| Retained earnings | -366,126 | -357,910 | -334,048 | -311,637 | -261,748 |
| Other shareholders' equity | 3,316 | 3,257 | 3,383 | 3,433 | 3,214 |
| TOTAL | $-1,926 | $5,922 | $26,897 | $46,963 | $29,369 |
| Total Liabilities And Equity | $10,067 | $28,923 | $53,015 | $55,720 | $36,432 |